LEP and cancer: Although the underlying mechanisms are still unclear, both leptin and its receptor expression and function have been positively correlated with cancer progression in some endocrine-related cancers [137] and this effect seems to be mainly mediated by LEPR activation of PI3K, ERK1/2 and Jak2/Stat3 signaling pathways [138,139,140,141].